- Top Workplaces
- Tarsus Pharmaceuticals
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing the development and commercialization of therapeutic candidates to address highly prevalent diseases with limited treatment options across a range of therapeutic categories including eye care, dermatology, and infectious disease prevention. Their lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, formerly known as TP-03, is FDA-approved in the United States for the treatment of Demodex blepharitis. TP-03 is also being developed for the treatment of Meibomian Gland Disease in patients with Demodex mites. Learn more at TarsusRx.com.
Purpose
Tarsus is a biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address highly prevalent diseases with limited treatment options. Serving patient needs is our passion; delivering revolutionary treatments is our mission.
Vision
A future in which patient needs are met through boundless therapeutic ingenuity.
Mission
Focusing on unmet needs, we apply proven science and new technology to revolutionize treatment for patients, starting with eye care.
Values
- We are a company that strives to embody the values of commitment, empowerment, and teamwork.
- Commitment - Our patients come first. We’re committed to them, and then to our stakeholders. We operate at the highest standard of integrity and are uncompromising in our dedication to science and disease understanding.
Empowerment - We champion innovation. We’re entrusted to make a real difference each day. We’re proactive and determined in every goal we set, maintaining our sense of urgency by focusing on what’s most important.
Teamwork - Together we amplify impact. We believe diversity drives better results. We hold ourselves accountable, embrace challenges, and strive for excellence while having fun and celebrating our successes.
Headquarters
Irvine, CA
Employees
250 US Employees
Industry
Pharmaceuticals